Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial

被引：0

作者：

Yamanaka, R ^{[1
]}

Homma, J ^{[1
]}

Yajima, N ^{[1
]}

Tsuchiya, N ^{[1
]}

Tanaka, R ^{[1
]}

机构：

[1] Niigata Univ, Brain Res Inst, Niigata, Japan

来源：

MOLECULAR THERAPY | 2004年 / 9卷

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

254

引用

页码：S98 / S98

页数：1

共 50 条

[31] FUNCTIONAL CAPACITY OF TUMOR LYSATE-PULSED MONOCYTE-DERIVED DENDRITIC CELLS INDUCING IN VITRO IMMUNE RESPONSES
Pinho, C.
Lopes, S.
Amado, F.
Verdelho, A.
Abreu de Sousa, J.
Roncon, S.
HAEMATOLOGICA, 2016, 101 : 745 - 745
[32] Vaccination therapy of pancreatic carcinoma patients with autologous, tumor-lysate pulsed dendritic cells: Results of a phase II study
Bauer, C.
Dauer, M.
Schnurr, M.
Jauch, K.
Ruettinger, D.
Conrad, C.
Bruns, C.
Emmerich, B.
Endres, S.
Eigler, A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[33] A phase II randomized trial with adjuvant autologous tumor lysate-pulsed dendritic cells (DC) in resected stage III-IV melanoma patients: Preliminary immunological results
Ridolfi, L.
Bulgarelli, J.
Piccinini, C.
Carloni, S.
Granato, A.
Petrini, M.
De Rosa, F.
Tazzari, M.
Pancisi, E.
Ancarani, V.
Turci, L.
Gentili, G.
Valmorri, L.
Guidoboni, M.
ANNALS OF ONCOLOGY, 2021, 32 : S1394 - S1394
[34] A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Lana E Kandalaft
Cheryl L Chiang
Janos Tanyi
Greg Motz
Klara Balint
Rosemarie Mick
George Coukos
Journal of Translational Medicine, 11
[35] A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Kandalaft, Lana E.
Chiang, Cheryl L.
Tanyi, Janos
Motz, Greg
Balint, Klara
Mick, Rosemarie
Coukos, George
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[36] Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-β gene therapy for malignant glioma in an experimental mouse intracranial glioma
Saito, R
Mizuno, M
Nakahara, N
Tsuno, T
Kumabe, T
Yoshimoto, T
Yoshida, J
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) : 777 - 782
[37] Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
Ridolfi, Laura
de Rosa, Francesco
Fiammenghi, Laura
Petrini, Massimiliano
Granato, Anna Maria
Ancarani, Valentina
Pancisi, Elena
Soldati, Valentina
Cassan, Serena
Bulgarelli, Jenny
Riccobon, Angela
Gentili, Giorgia
Nanni, Oriana
Framarini, Massimo
Tauceri, Francesca
Guidoboni, Massimo
BMJ OPEN, 2018, 8 (08):
[38] Vaccination of myeloma patients with monoclonal immunoglobulin loaded dendritic cells:: preclinical and first clinical results of a phase I/II clinical trial
Ocadlikova, D.
Zahradova, L.
Kovarova, L.
Smejkalova, J.
Pour, L.
Vidlakova, P.
Kyjovska, D.
Stejskalova, A.
Novotna, H.
Penka, M.
Michalek, J.
Hajek, R.
BLOOD REVIEWS, 2007, 21 : S129 - S129
[39] A PHASE I TRIAL OF VACCINATION WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE DERIVED FROM AN ALLOGENEIC GLIOBLASTOMA STEMLIKE CELL LINE FOR PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA
Hu, Jethro
Rudnick, Jeremy
Wheeler, Christopher
Mazer, Mia
Wang, HongQiang
Black, Keith
Yu, John
NEURO-ONCOLOGY, 2018, 20 : 4 - 4
[40] VACCINATION OF DENDRITIC CELLS LOADED BY ELECTROPORATION WITH AUTOLOGOUS TUMOR LYSATE FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: EVALUATION OF SAFETY AND IMMUNE RESPONSE
Kanemura, Yonehiro
Sumida, Miho
Yoshioka, Ema
Yamamoto, Atsuyo
Kanematsu, Daisuke
Takada, Ai
Nonaka, Masahiro
Nakajima, Shin
Goto, Shigenori
Kamigaki, Takashi
Takahara, Masashi
Maekawa, Ryuji
Shofuda, Tomoko
Moriuchi, Shusuke
Yamasaki, Mami
NEURO-ONCOLOGY, 2013, 15 : 70 - 70

← 1 2 3 4 5 →